Drug Shortage Report for GALLIUM (GA67) CITRATE INJECTION

Last updated on 2024-01-26 History
Report ID 215600
Drug Identification Number 02327813
Brand name GALLIUM (GA67) CITRATE INJECTION
Common or Proper name Gallium (Ga 67) Citrate injection
Company Name CURIUM CANADA INC
Market Status MARKETED
Active Ingredient(s) GALLIUM CITRATE GA 67
Strength(s) 74MBq
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 6 & 12 mCi
ATC code V09HX
ATC description
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2024-01-14
Actual start date 2024-01-14
Estimated end date 2024-01-21
Actual end date 2024-01-21
Shortage status Resolved
Updated date 2024-01-26
Company comments Due to a mechanical issue, we were unable to execute cyclotron production of Ga-67 raw material. As a consequence, Gallium Citrate Ga 67 Injection will not be available for shipment January 14-18, 2024. The next lot is scheduled to release Sunday, Jan 21. We apologize for any inconvenience caused by this issue.
Health Canada comments
Tier 3 Status No
Contact Address 2572 BOUL. DANIEL-JOHNSON
LAVAL, QUEBEC
CANADA H7T 2R3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2024-01-26 French Compare
v6 2024-01-26 English Compare
v5 2024-01-16 French Compare
v4 2024-01-16 English Compare
v3 2024-01-15 English Compare
v2 2024-01-11 French Compare
v1 2024-01-11 English Compare

Showing 1 to 7 of 7